CIBC Asset Management Inc Sells 129,216 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

CIBC Asset Management Inc reduced its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 54.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 108,286 shares of the pharmacy operator's stock after selling 129,216 shares during the quarter. CIBC Asset Management Inc's holdings in Walgreens Boots Alliance were worth $970,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Iron Horse Wealth Management LLC increased its holdings in shares of Walgreens Boots Alliance by 162.5% in the 2nd quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator's stock worth $25,000 after buying an additional 1,300 shares during the last quarter. Blue Trust Inc. grew its holdings in shares of Walgreens Boots Alliance by 87.0% during the 2nd quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator's stock valued at $28,000 after purchasing an additional 1,081 shares during the last quarter. Continuum Advisory LLC grew its holdings in shares of Walgreens Boots Alliance by 71.2% during the 2nd quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator's stock valued at $30,000 after purchasing an additional 1,020 shares during the last quarter. Sentry Investment Management LLC bought a new position in shares of Walgreens Boots Alliance during the 3rd quarter valued at $30,000. Finally, Eastern Bank bought a new position in shares of Walgreens Boots Alliance during the 3rd quarter valued at $33,000. 58.59% of the stock is currently owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Trading Up 0.4 %

NASDAQ:WBA traded up $0.03 during trading hours on Thursday, hitting $8.27. 15,659,300 shares of the stock traded hands, compared to its average volume of 17,476,879. Walgreens Boots Alliance, Inc. has a 1 year low of $8.08 and a 1 year high of $27.05. The stock has a 50 day moving average price of $9.16 and a 200 day moving average price of $11.67. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 EPS for the quarter, topping the consensus estimate of $0.36 by $0.03. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The firm had revenue of $37.50 billion for the quarter, compared to the consensus estimate of $35.75 billion. During the same quarter in the previous year, the firm earned $0.67 earnings per share. The company's quarterly revenue was up 5.9% compared to the same quarter last year. Equities research analysts predict that Walgreens Boots Alliance, Inc. will post 1.53 EPS for the current year.

Walgreens Boots Alliance Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 12th. Investors of record on Monday, November 18th will be paid a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 12.09%. The ex-dividend date of this dividend is Monday, November 18th. Walgreens Boots Alliance's payout ratio is -9.99%.

Analyst Upgrades and Downgrades

WBA has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. cut their price target on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an "overweight" rating on the stock in a report on Friday, August 30th. Barclays raised their price target on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an "underweight" rating in a report on Wednesday, October 16th. Morgan Stanley cut their price target on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an "underweight" rating on the stock in a report on Friday, October 11th. Truist Financial cut their price target on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a "hold" rating on the stock in a report on Monday, October 7th. Finally, TD Cowen dropped their target price on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a "buy" rating for the company in a research report on Tuesday, October 22nd. Four research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $12.88.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.